Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
DEPISTORL - THANCS (Trial of Head And Neck Cancer Screening) Randomized Multicenter Trial to Assess the Impact of a Screening Program for Heavy Alcohol Drinkers and Smokers Treated in Alcohol Addiction Clinics on Upper Aerodigestive Tract Cancer Mortality.
2 other identifiers
interventional
1,993
1 country
35
Brief Summary
Randomized multicenter trial to assess the impact of a screening program for heavy alcohol drinkers and smokers treated in alcohol addiction clinics on upper aerodigestive tract cancer mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jun 2006
Longer than P75 for phase_3
35 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 21, 2006
CompletedFirst Submitted
Initial submission to the registry
August 1, 2006
CompletedFirst Posted
Study publicly available on registry
August 2, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2015
CompletedMay 16, 2017
May 1, 2017
9.5 years
August 1, 2006
May 15, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Upper aerodigestive tract cancer mortality
5 years
Secondary Outcomes (3)
Screening test morbidity
1 week
Upper aerodigestive tract cancer incidence
5 years
Upper aerodigestive tract cancer stage
5 years
Study Arms (2)
Control
NO INTERVENTIONAnnual auto questionnaire
Screening
EXPERIMENTALAnnual screening of Head and Neck cancer
Interventions
Eligibility Criteria
You may qualify if:
- current or previous heavy smokers (smoked \>= 20 years) and alcohol drinkers who need specialized care
You may not qualify if:
- Head and neck clinical examination during the past 6 months
- History of squamous cell carcinoma of the upper aero-digestive tract.
- Recent digestive hemorrhage from varicose esophagus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (35)
Centre Hospitalier MONTPERRIN
Aix-en-Provence, 13100, France
CHIAB Annemasse Bonneville
Annemasse, 74 100, France
Centre Hospitalier d'ARRAS
Arras, 62000, France
CHS de L'Yonne
Auxerre, 89000, France
Chg Beziers
Béziers, 34525, France
C.A.S.A.
Clermont, 60600, France
CHU Hôpital Gabriel Montpied
Clermont-Ferrand, 63003, France
Centre Hospitalier de DIEPPE
Dieppe, 76200, France
CHU le Bocage
Dijon, 21034, France
Centre Hospitalier Louis Sevestre
La Membrolle-sur-Choisille, 37390, France
Centre Hospitalier du Mans
Le Mans, 72037, France
Centre Hospitalier de LENS
Lens, 62300, France
CHU de Lille
Lille, 59, France
CHBS Lorient
Lorient, 56322, France
Centre hospitalier Lyon sud
Lyon, 69, France
Centre Hospitalier des Chanaux
Mâcon, 71, France
CHU de Nancy
Nancy, 54035, France
CHU de Nantes
Nantes, 44, France
Hôpital ARCHET II
Nice, 06202, France
Centre ANPAA d'Orléans
Orléans, 45000, France
Centre Paul Cézanne
Orléans, 45000, France
Hôpital de la Source
Orléans, 45067, France
Clinique Philae
Pont-Péan, 35131, France
Centre Hospitalier du Centre Bretagne
Pontivy, 56306, France
Centre ANPAA 51 de Reims
Reims, 51100, France
CHU Hôpital Pontchaillou
Rennes, 35033, France
Hopital de Saint Cloud
Saint-Cloud, 92, France
CHR de la Réunion
Saint-denis de La Reunion, 97405, France
Ch Saint-Egreve
Saint-Égrève, 38521, France
Centre de soins de suite Marienbronn
Soultz-sous-Forêts, 67250, France
CHU de Strasbourg - Hôpital Hautepierre
Strasbourg, 67098, France
Hôpitaux du Leman
Thonon-les-Bains, 74200, France
Chba Vannes
Vannes, 56000, France
Hopital Paul Brousse
Villejuif, 94805, France
Institut_Gustave-Roussy
Villejuif, 94805, France
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphane TEMAM, PhD
Gustave Roussy, Cancer Campus, Grand Paris
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2006
First Posted
August 2, 2006
Study Start
June 21, 2006
Primary Completion
December 18, 2015
Study Completion
December 18, 2015
Last Updated
May 16, 2017
Record last verified: 2017-05